Inventor
TAKADA YOSHIKAZU
US17 patents
⚠️ This page may combine multiple inventors who share the name “TAKADA YOSHIKAZU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NIPPON KOKAN KK
8 patentsUS5089061AFeb 18, 1992
Method for producing high silicon steel strip in a continuously treating line
NIPPON KOKAN KK25 citations92
US5993568ANov 30, 1999
Soft magnetic alloy sheet having low residual magnetic flux density
NIPPON KOKAN KK21 citations91
US4773948ASep 27, 1988
Method of producing silicon iron sheet having excellent soft magnetic properties
NIPPON KOKAN KK12 citations72
US4715905ADec 29, 1987
Method of producting thin sheet of high Si-Fe alloy
NIPPON KOKAN KK16 citations72
US6527876B2Mar 4, 2003
Silicon steel sheet and method for producing the same
NIPPON KOKAN KK10 citations69
US4986341AJan 22, 1991
Process for making non-oriented high silicon steel sheet
NIPPON KOKAN KK10 citations69
US4052235AOct 4, 1977
Method of preventing oxidation during water quenching of steel strip
NIPPON KOKAN KK17 citations69
US4832762AMay 23, 1989
Method for producing thin steel sheet of high magnetic permeability
NIPPON KOKAN KK6 citations62
TAKADA YOSHIKAZU
3 patentsUS8168591B2May 1, 2012
Compositions and methods related to anti-FGF agents
TAKADA YOSHIKAZU24 citations90
US8796209B2Aug 5, 2014
Compositions and methods related to anti-FGF agents
TAKADA YOSHIKAZU0 citations50
US8685403B2Apr 1, 2014
Insulin-like growth factor signaling and integrin
TAKADA YOSHIKAZU0 citations40
UNIV CALIFORNIA
3 patentsUS11229681B2Jan 25, 2022
Dominant-negative FGF2 antagonists
UNIV CALIFORNIA0 citations61
US12054517B2Aug 6, 2024
Myeloid differentiation factor 2 (MD2) signaling and modulation
UNIV CALIFORNIA0 citations60
US10591471B2Mar 17, 2020
Suppression of SPLA2-integrin binding for treating an inflammatory condition or suppressing cell proliferation
UNIV CALIFORNIA0 citations50